-
Article
Open AccessReversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies
The association between loss of BRCA1/2 and a homologous recombination deficiency phenotype is lineage dependent. In BRCA-associated cancers such as breast, ovarian, pancreas and prostate, this phenotype confers ...
-
Article
Open AccessOrdered and deterministic cancer genome evolution after p53 loss
Although p53 inactivation promotes genomic instability1 and presents a route to malignancy for more than half of all human cancers2,3, the patterns through which heterogenous TP53 (encoding human p53) mutant geno...
-
Article
Open AccessPilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
PD-1 blockade (nivolumab) efficacy remains modest for metastatic sarcoma. In this paper, we present an open-label, non-randomized, non-comparative pilot study of bempegaldesleukin, a CD122-preferential interle...
-
Article
Open AccessAKT mutant allele-specific activation dictates pharmacologic sensitivities
AKT- a key molecular regulator of PI-3K signaling pathway, is somatically mutated in diverse solid cancer types, and aberrant AKT activation promotes altered cancer cell growth, survival, and metabolism1–8. The m...
-
Article
Anatomic position determines oncogenic specificity in melanoma
Oncogenic alterations to DNA are not transforming in all cellular contexts1,2. This may be due to pre-existing transcriptional programmes in the cell of origin. Here we define anatomic position as a major determi...
-
Article
Author Correction: Tumour lineage shapes BRCA-mediated phenotypes
An Amendment to this paper has been published and can be accessed via a link at the top of the paper.
-
Article
Tumour lineage shapes BRCA-mediated phenotypes
Mutations in BRCA1 and BRCA2 predispose individuals to certain cancers1–3, and disease-specific screening and preventative strategies have reduced cancer mortality in affected patients4,5. These classical tumour-...